Q2 2013

Filed Aug 14, 2013 · 10-Q · 45 days after period end · 0001121781-13-000294

Q2 2013 · 10-Q

Revenue

$222.00K

−75.7% vs Q2 2012

Net Income

-$1.75M

N/M vs Q2 2012

EPS Diluted

-$0.04

N/M vs Q2 2012

Gross Profit-$3,000N/M

Operating Income

Same quarter

Metric	Q2 2013	Q2 2012	Q2 2011	Q2 2010
Revenue	$222.00K	$915.00K	$913.00K	$805.00K
Net Income	-$1.75M	-$1.17M	-$496.00K	-$559.00K
EPS Diluted	-$0.04	-$0.02	-$0.01	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR